Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Genzyme
 More »

  • Sanofi Opens Cancer Research Hub in Cambridge, MA
    The new facility expands to about 5,000 employees-including some 1,700 researchers-the combined greater Boston workforce of Sanofi and its Genzyme biotech subsidiary, which is ...
    9-20-2013
  • Genzyme's MS Drug Lemtrada Receives EU Authorization
    Genzyme said today it won marketing authorization from the European Union for its multiple ... the European Union's second marketing nod for a Genzyme MS treatment in less than a month. ...
    9-17-2013
  • Double Manufacturing Deals for Sanofi
    Meanwhile, Genzyme, another Sanofi company, entered a multi-year development and manufacturing supply agreement with St. Louis-based CMO Gallus Biopharmaceuticals in which Gallus ...
    8-1-2013
  • Isis Wins $2M Milestone Payment from GSK for Antisense Drug Candidate
    The company's lead product, the once-weekly injection anti-LDL cholesterol drug Kynamro, is being commercialized by collaboration partner Genzyme for patients with the rare genetic ...
    7-30-2013
  • AskBio, Genzyme Ink Gene Therapy Cross-Licensing Agreement
    which the firm is granting Genzyme rights to its Duplex gene therapy vector technology. ... Genzyme will be using the Duplex technology for internal product development. ...
    7-17-2013
  • Top 20 Corporate Venture Funds
    ... Year established: 2001; name changed in 2011 #11. (tie) Sanofi-Genzyme BioVentures (formerly Genzyme Ventures) Resources: $100 million strategic corporate venture capital ...
    6-14-2013
  • Strategies to Optimize Cell Culture
    Scientist using a small-scale benchtop bioreactor. [Genzyme] With the worldwide appetite ... Our cells tend to grow a little better at scale than at small scale." Genzyme adds more CO ...
    6-1-2013
  • GEN | Biolinks
    ... Biopharmaceuticals GE Healthcare Life Sciences Gene Link Genentech GenTech Scientific Genzyme Georgetown University Georgia Bio Georgia Department of Economic Development Geron ...
  • E&Y: Biotechs Must Walk the Walk on Drug Value
    ... M&A activity rises: The total value of mergers and acquisitions involving U.S. or European biotechs rose last year to $27.4 billion, up 9% over 2011 excluding the Sanofi-Genzyme ...
    4-22-2013
  • Top 20 Best-Selling Drugs Approved and Launched During 2012
    (teriflunomide) 2012 sales: $9.1 million (€7 million) 4 Marketer(s): Sanofi (Genzyme) Indication(s): Relapsing forms of multiple sclerosis Date of FDA approval: September ...
    4-4-2013
  • Is This Gene Therapy's Breakout Moment?
    very few, if any, gene-therapy programs being developed by the pharma industry's biggest players. The most advanced such programs have been overseen by Sanofi's Genzyme subsidiary. ...
    4-1-2013
  • Biopharmas Cooling to Licensing Deals as Patent Cliff Fears Ease
    The 2011 figure includes Sanofi's $20.1 billion acquisition of Genzyme. One area where licensing and M&A activity could increase this year, Urquhart said, is orphan drugs, whose ...
    3-28-2013
  • Novel Platform for Immunotherapies Created
    The platform will be based at Genzyme Polyclonals site in Lyon-Gerland area for an ... The platform will remain Sanofi's exclusive property. Sanofi and Genzyme will act as ...
    3-26-2013
  • Top 10 Biopharma Layoffs of 2012
    ... Part of five-year, €2 billion ($2.7 billion) cost-cutting initiative announced in September 2011, following $20.1 billion acquisition of Genzyme earlier that year and loss of ...
    3-15-2013
  • Is This Gene Therapy's Breakout Moment?
    very few, if any, gene-therapy programs being developed by the pharma industry's biggest players. The most advanced such programs have been overseen by Sanofi's Genzyme subsidiary. ...
    3-4-2013

  • Journal Articles

  • Bringing Molecular Biology to Bear on Adhesion Prevention: Postsurgica...
    Robert A. Hammer, Abraham N. Morse, Jeffrey L. Cornella, Rebecca S. Keller, Joseph Hentz, John A. McDonald, Joseph C. Loftus
    Journal of Gynecologic Surgery
    Journal of Gynecologic Surgery Objective: Seprafilm,® (Genzyme, Cambridge, MA) an absorbable adhesion barrier incorporating hyaluronic acid (HA), a high molecular mass ...
  • Validation of a Mouse Adhesion Reduction Model Using Seprafilm...
    Abraham N. Morse, Robert A. Hammer, Jeffrey L. Cornella, Joseph C. Loftus
    Journal of Gynecologic Surgery
    This model has been validated using a hyaluronan/carboxymethylcellulose (HA/CMC) barrier (Seprafilm®; Genzyme, Somerville, NJ) currently in clinical use. Methods: Adult, FVB mice ...
  • Laparoscopic Adhesiolysis and Placement of Seprafilm(tm): A New...
    Leena Khaitan, Stefan Scholz, William O. Richards
    Journal of Laparoendoscopic& Advanced Surgical Techniquesand Part B, Videoscopy
    Many surgeons argue that operative treatment of these patients exacerbates symptoms because of the continued adhesion formation following each procedure. Seprafilm(tm) (Genzyme, ...
  • Recombinant Human Thyrotropin is Helpful in the Follow-Up and...
    Susanne Kohlfuerst, Isabelle Igerc, Peter Lind
    Thyroid
    obtained a TSH level of greater than 80 mU/L after two injections of rhTSH (Thyrogen, Genzyme Corp., Cambridge, MA) 0.9 mg intramuscularly 24 hours and 48 hours before the ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll